Source: International Journal of Biochemistry. Unidade: FM
Subjects: DIABETES MELLITUS (METABOLISMO), DIABETES MELLITUS (EFEITOS DE DROGAS), GLICEMIA (METABOLISMO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Adriana P. et al. Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products. International Journal of Biochemistry, v. 38, n. 3, p. 392-403, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.biocel.2005.09.016. Acesso em: 14 fev. 2026.APA
Machado, A. P., Pinto, R. S., Moysés, Z. P., Nakandakare, E. R., Quintão, E. C. R., & Passarelli, M. (2006). Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products. International Journal of Biochemistry, 38( 3), 392-403. doi:10.1016/j.biocel.2005.09.016NLM
Machado AP, Pinto RS, Moysés ZP, Nakandakare ER, Quintão ECR, Passarelli M. Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products [Internet]. International Journal of Biochemistry. 2006 ; 38( 3): 392-403.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1016/j.biocel.2005.09.016Vancouver
Machado AP, Pinto RS, Moysés ZP, Nakandakare ER, Quintão ECR, Passarelli M. Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products [Internet]. International Journal of Biochemistry. 2006 ; 38( 3): 392-403.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1016/j.biocel.2005.09.016
